167 related articles for article (PubMed ID: 35307792)
21. Classical scrapie prions in ovine blood are associated with B lymphocytes and platelet-rich plasma.
Dassanayake RP; Schneider DA; Truscott TC; Young AJ; Zhuang D; O'Rourke KI
BMC Vet Res; 2011 Nov; 7():75. PubMed ID: 22112371
[TBL] [Abstract][Full Text] [Related]
22. Capillary electrophoresis of the scrapie prion protein from sheep brain.
Schmerr MJ; Goodwin KR; Cutlip RC
J Chromatogr A; 1994 Oct; 680(2):447-53. PubMed ID: 7981826
[TBL] [Abstract][Full Text] [Related]
23. Emerging therapeutic agents for transmissible spongiform encephalopathies: a review.
Koster T; Singh K; Zimmermann M; Gruys E
J Vet Pharmacol Ther; 2003 Oct; 26(5):315-26. PubMed ID: 14633183
[TBL] [Abstract][Full Text] [Related]
24. Transmission of scrapie and sheep-passaged bovine spongiform encephalopathy prions to transgenic mice expressing elk prion protein.
Tamgüney G; Miller MW; Giles K; Lemus A; Glidden DV; DeArmond SJ; Prusiner SB
J Gen Virol; 2009 Apr; 90(Pt 4):1035-1047. PubMed ID: 19264659
[TBL] [Abstract][Full Text] [Related]
25. Abnormal prion protein in genetically resistant sheep from a scrapie-infected flock.
Madec JY; Simon S; Lezmi S; Bencsik A; Grassi J; Baron T
J Gen Virol; 2004 Nov; 85(Pt 11):3483-3486. PubMed ID: 15483266
[TBL] [Abstract][Full Text] [Related]
26. Cellular toxicity of scrapie prions in prion diseases; a biochemical and molecular overview.
Esmaili M; Eldeeb M
Mol Biol Rep; 2023 Feb; 50(2):1743-1752. PubMed ID: 36446981
[TBL] [Abstract][Full Text] [Related]
27. Development of antibody fragments for immunotherapy of prion diseases.
Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein.
Vilette D; Andreoletti O; Archer F; Madelaine MF; Vilotte JL; Lehmann S; Laude H
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4055-9. PubMed ID: 11259656
[TBL] [Abstract][Full Text] [Related]
29. Immunoaffinity purification and neutralization of scrapie prion infectivity.
Gabizon R; McKinley MP; Groth D; Prusiner SB
Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6617-21. PubMed ID: 3137571
[TBL] [Abstract][Full Text] [Related]
30. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms.
Bossers A; Belt PBGM ; Raymond GJ; Caughey B; de Vries R; Smits MA
Proc Natl Acad Sci U S A; 1997 May; 94(10):4931-6. PubMed ID: 9144167
[TBL] [Abstract][Full Text] [Related]
31. In vitro prion protein conversion suggests risk of bighorn sheep (Ovis canadensis) to transmissible spongiform encephalopathies.
Morawski AR; Carlson CM; Chang H; Johnson CJ
BMC Vet Res; 2013 Aug; 9():157. PubMed ID: 23938169
[TBL] [Abstract][Full Text] [Related]
32. Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures.
Cronier S; Beringue V; Bellon A; Peyrin JM; Laude H
J Virol; 2007 Dec; 81(24):13794-800. PubMed ID: 17913812
[TBL] [Abstract][Full Text] [Related]
33. 5-Methylcytosine and 5-Hydroxymethylcytosine in Scrapie-Infected Sheep and Mouse Brain Tissues.
Hernaiz A; Sentre S; Betancor M; López-Pérez Ó; Salinas-Pena M; Zaragoza P; Badiola JJ; Toivonen JM; Bolea R; Martín-Burriel I
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675131
[TBL] [Abstract][Full Text] [Related]
34. Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie.
Solassol J; Crozet C; Perrier V; Leclaire J; Béranger F; Caminade AM; Meunier B; Dormont D; Majoral JP; Lehmann S
J Gen Virol; 2004 Jun; 85(Pt 6):1791-1799. PubMed ID: 15166465
[TBL] [Abstract][Full Text] [Related]
35. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.
Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L
J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946
[TBL] [Abstract][Full Text] [Related]
36. New approaches for the selection and evaluation of anti-prion organic compounds.
Cordeiro Y; Ferreira NC
Mini Rev Med Chem; 2015; 15(2):84-92. PubMed ID: 25723455
[TBL] [Abstract][Full Text] [Related]
37. Biochemical properties of protease resistant prion protein PrPsc in natural sheep scrapie.
Madec JY; Vanier A; Dorier A; Bernillon J; Belli P; Baron T
Arch Virol; 1997; 142(8):1603-12. PubMed ID: 9672622
[TBL] [Abstract][Full Text] [Related]
38. Cellular prion protein is expressed on peripheral blood mononuclear cells but not platelets of normal and scrapie-infected sheep.
Herrmann LM; Davis WC; Knowles DP; Wardrop KJ; Sy MS; Gambetti P; O' Rourke KI
Haematologica; 2001 Feb; 86(2):146-53. PubMed ID: 11224483
[TBL] [Abstract][Full Text] [Related]
39. Immunoaffinity purification and neutralization of scrapie prions.
Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
[TBL] [Abstract][Full Text] [Related]
40. PrP knock-out and PrP transgenic mice in prion research.
Weissmann C; Flechsig E
Br Med Bull; 2003; 66():43-60. PubMed ID: 14522848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
